PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
-1.19%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$828M
AUM Growth
-$131M
(-14%)
Cap. Flow
-$56.7M
Cap. Flow
% of AUM
-6.85%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
264
New
28
Increased
49
Reduced
25
Closed
53
Top Buys
| 1 |
Biogen
BIIB
|
$31M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 3 |
C4 Therapeutics
CCCC
|
$14.4M |
| 4 |
Bio-Techne
TECH
|
$10.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$10.7M |
Top Sells
| 1 |
Natera
NTRA
|
$22M |
| 2 |
The Beauty Health Co
SKIN
|
$14.4M |
| 3 |
DexCom
DXCM
|
$14.1M |
| 4 |
ICU Medical
ICUI
|
$13.9M |
| 5 |
LivaNova
LIVN
|
$12.9M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Materials | 1.3% |
| 3 | Industrials | 0.61% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
TG Therapeutics
TGTX
$4.95B
| $3.12M | 0.1% |
+328,187
| New | +$3.12M |
|
52
Standard BioTools
LAB
$485M
| $3.05M | 0.1% |
+850,000
| New | +$3.05M |
|
|
ICAD
53
DELISTED
iCAD Inc
ICAD
| $3M | 0.1% |
+672,989
| New | +$3M |
|
54
United Therapeutics
UTHR
$17.2B
| $2.97M | 0.1% |
16,561
+5,803
| +54% | +$1.04M |
|
55
Travere Therapeutics
TVTX
$1.86B
| $2.84M | 0.09% |
110,225
+300
| +0.3% | +$7.73K |
|
|
BLU
56
DELISTED
BELLUS Health Inc.
BLU
| $2.68M | 0.09% |
390,097
+2,300
| +0.6% | +$15.8K |
|
|
APEN
57
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.58M | 0.08% |
427,057
+52,400
| +14% | +$317K |
|
|
LHDX
58
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $2.45M | 0.08% |
687,213
-478,017
| -41% | -$1.71M |
|
59
Peloton Interactive
PTON
$3.31B
| $2.11M | 0.07% |
+80,000
| New | +$2.11M |
|
60
Lyra Therapeutics
LYRA
$11.7M
| $2.09M | 0.07% |
10,411
+66
| +0.6% | +$13.3K |
|
61
Adaptive Biotechnologies
ADPT
$1.97B
| $2.08M | 0.07% |
+150,000
| New | +$2.08M |
|
62
Sarepta Therapeutics
SRPT
$1.94B
| $2.02M | 0.07% |
+25,850
| New | +$2.02M |
|
63
AstraZeneca
AZN
$254B
| $1.99M | 0.06% |
+30,000
| New | +$1.99M |
|
64
Viridian Therapeutics
VRDN
$1.51B
| $1.95M | 0.06% |
105,460
+600
| +0.6% | +$11.1K |
|
65
Liquidia Corp
LQDA
$2.48B
| $1.81M | 0.06% |
251,604
+200,200
| +389% | +$1.44M |
|
|
UBX
66
DELISTED
Unity Biotechnology
UBX
| $1.77M | 0.06% |
+157,814
| New | +$1.77M |
|
67
Merus
MRUS
$4.96B
| $1.76M | 0.06% |
66,547
+7,887
| +13% | +$209K |
|
68
Schrodinger
SDGR
$1.4B
| $1.71M | 0.06% |
+50,000
| New | +$1.71M |
|
69
10x Genomics
TXG
$1.68B
| $1.69M | 0.05% |
22,257
-39,700
| -64% | -$3.02M |
|
|
DALS
70
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $1.6M | 0.05% |
164,834
| – | – |
|
71
Protagonist Therapeutics
PTGX
$3.67B
| $1.55M | 0.05% |
+65,371
| New | +$1.55M |
|
|
TCDA
72
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.49M | 0.05% |
+180,816
| New | +$1.49M |
|
|
KDNY
73
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.39M | 0.05% |
85,236
-5,005
| -6% | -$81.9K |
|
74
Phathom Pharmaceuticals
PHAT
$822M
| $1.39M | 0.05% |
102,328
+600
| +0.6% | +$8.17K |
|
75
WM Technology
MAPS
$122M
| $1.39M | 0.05% |
+178,000
| New | +$1.39M |
|